IC
UTHR icon

IEQ Capital’s United Therapeutics UTHR Stock Holding History

IEQ Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Sell
26,102
-9,813
-27% -$5.53M 0.07% 276
2026
Q1 		$21.3M Sell
35,915
-23,044
-39% -$11.5M 0.1% 201
2025
Q4 		$28.7M Buy
58,959
+46,714
+381% +$21.8M 0.09% 141
2025
Q3 		$5.13M Buy
12,245
+6,417
+110% +$2.16M 0.02% 479
2025
Q2 		$1.67M Buy
+5,828
New +$1.74M 0.01% 694
2025
Q1 		– Sell
-6,852
Closed -$2.42M – 1740
2024
Q4 		$2.42M Buy
6,852
+5,171
+308% +$1.9M 0.02% 450
2024
Q3 		$602K Buy
+1,681
New +$568K 0.01% 694

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

IEQ Capital's UTHR Position: Q2 2026 in Review

IEQ Capital reduced its United Therapeutics (UTHR) stake by 27% in Q2 2026, selling an estimated $5.53M and leaving 26,102 shares worth $14.1M. The position accounts for 0.07% of the portfolio, ranked #276.

IEQ Capital first reported a position in UTHR in Q3 2024 and has held it in 7 quarters since. The position peaked at $28.7M in Q4 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • IEQ Capital held 26,102 shares of United Therapeutics worth $14.1M as of Q2 2026.
  • IEQ Capital sold 9,813 United Therapeutics shares in Q2 2026, an estimated $5.53M.
  • United Therapeutics made up 0.07% of IEQ Capital's portfolio in Q2 2026, its #276 holding.
  • IEQ Capital first reported a position in United Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • IEQ Capital's United Therapeutics position peaked at $28.7M in Q4 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.